Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Soleno Therapeutics Inc shares valued at $22,410 were purchased by PATRICIA HIRANO on Jun 24 ’25. At $84.25 per share, PATRICIA HIRANO acquired 266 shares.
Also, Hirano Patricia C sold 3,782 shares, netting a total of over 265,156 in proceeds. Following the sale of shares at $70.11 each, the insider now holds 27,036 shares.
Before that, PATRICIA HIRANO had added 3,782 shares to its account. In a trade valued at $265,156, the Officer bought Soleno Therapeutics Inc shares for $70.11 each.
As published in their initiating research note from TD Cowen on June 23, 2025, Soleno Therapeutics Inc [SLNO] has been a Buy and the price target has been revised to $110. As of December 02, 2024, Stifel has reiterated its “Buy” rating for SLNO. Earlier on December 02, 2024, Robert W. Baird resumed its rating. Their recommendation was “an Outperform” for SLNO stock.
Analyzing SLNO Stock Performance
On last trading session,, Soleno Therapeutics Inc [NASDAQ: SLNO] rose 1.92% to $85.79. The stock’s lowest price that day was $82.51, but it reached a high of $86.67 in the same session. During the last five days, there has been a surge of approximately 10.55%. Over the course of the year, Soleno Therapeutics Inc shares have jumped approximately 108.48%. Shares of the company reached a 52-week high of $86.67 on 06/25/25 and a 52-week low of $41.50 on 01/15/25.
Support And Resistance Levels for Soleno Therapeutics Inc (SLNO)
According to the 24-hour chart, there is a support level at 83.28, which, if violated, would cause prices to drop to 80.78. In the upper region, resistance lies at 87.48. The next price resistance is at 89.18. RSI (Relative Strength Index) is 71.95 on the 14-day chart, showing overbought technical sentiment.
Is Soleno Therapeutics Inc subject to short interest?
Stocks of Soleno Therapeutics Inc saw a sharp steep in short interest on 2025-05-30 dropping by -0.18 million shares to 3.99 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 4.16 million shares. A decline of -4.4% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 5.39 of the overall float, the days-to-cover ratio (short ratio) decline to 5.39.
Which companies own the most shares of Soleno Therapeutics Inc (SLNO)?
In terms of Soleno Therapeutics Inc share price expectations, FactSet research, analysts set an average price target of 102 in the next 12 months, up nearly 21.18% from the previous closing price of $84.17. Analysts anticipate Soleno Therapeutics Inc stock to reach 105 by 2025, with the lowest price target being 81. In spite of this, 3 analysts ranked Soleno Therapeutics Inc stock as Buy at the end of 2025. On September 03, 2024, H.C. Wainwright assigned a price target of “a Buy” to the stock and initiated coverage with a $70.
